Angiopro Deepens Partnership with Ventripoint, Expands Role to Investor in DACH Region

Speyer, Germany - October 16, 2025. Angiopro Vertriebs- und Service GmbH (Angiopro) is pleased to announce the expansion of its partnership with Ventripoint Diagnostics Ltd. (Ventripoint), a leader in artificial intelligence (AI)-driven echocardiography solutions. Building upon a successful collaboration as the exclusive distributor in the DACH region, Angiopro has now become an investor in Ventripoint, reinforcing a long-term commitment to advancing cardiac diagnostics.

The partnership focuses on the VMS+ 4.0 software, Ventripoint's next-generation AI-powered platform that enables the creation of accurate 3D models of the heart from standard 2D echocardiography images. This innovative solution provides clinicians with rapid, reliable cardiac assessments, offering insights comparable to MRI but with enhanced accessibility and cost-effectiveness. Ventripoint's VMS+ transforms standard ultrasound scans into highly accurate 3D heart models in minutes, combining MRI-level precision with the speed, accessibility, and cost-effectiveness of echocardiography - truly redefining point-of-care cardiac diagnostics.

Benjamin Rieck, CEO of Angiopro GmbH, commented:
"Our strengthened partnership with Ventripoint reflects the trust and shared vision between our teams. By becoming investors, we are not only supporting their technology but also committing to a long-term journey of innovation and excellence in cardiac imaging for the DACH region."

The expanded partnership comes as Ventripoint continues to strengthen its position and resources, following the recent completion of its non-brokered convertible debenture financing.

Hugh MacNaught, CEO of Ventripoint Diagnostics Ltd., stated:
"We are thrilled to deepen our relationship with Angiopro. Their expertise and dedication in the DACH region have been invaluable, and this investment signifies mutual trust and the shared goal of transforming cardiac diagnostics together."

This expanded collaboration underscores both companies' dedication to delivering high-quality, reliable solutions that improve patient outcomes worldwide.

Angiopro Vertriebs- und Service GmbH
Heydenreichstr. 5
67346 Speyer

Melanie Braun
Senior Marketing Manager
kontakt@angiopro.de

About Angiopro Vertriebs- und Service GmbH
Angiopro GmbH is a specialized distributor based in Speyer, Rhineland-Palatinate, focusing on innovative products and technologies in cardiovascular medicine. The company's portfolio includes the distribution of vascular medical devices and the world's leading software for patient screening before and after cardiovascular interventions. www.angiopro.de

About Ventripoint Diagnostics Ltd.
Ventripoint is an industry leader in applying AI to echocardiography. Its VMS+ system uses proprietary knowledge-based reconstruction technology - developed over more than a decade - to deliver volumetric cardiac measurements equivalent to MRI. This affordable, gold-standard alternative gives cardiologists greater confidence in patient management. Compatible with all ultrasound systems and approved in the U.S., Europe, and Canada, VMS+ reflects Ventripoint's commitment to advancing patient care through innovation.

This release was published on openPR.